Patents by Inventor Mark Coopersmith
Mark Coopersmith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9414552Abstract: A smart irrigation system for an irrigation controller associated with an irrigation site is described herein. The smart irrigation system comprises a central control system having a user interface and a smart scheduler. The central control system is configured to receive a landscape information associated with the irrigation site. The landscape information is provided by a user via the user interface. The central control system is further configured to receive an environmental information associated with the irrigation site. The central control system is further configured to derive an irrigation schedule for the irrigation site based on the landscape information and the environmental information. The central control system being further configured to send the irrigation schedule. The smart scheduler comprises a data receiver, a processor, and a signal interface. The data receiver is configured to receive the irrigation schedule.Type: GrantFiled: February 2, 2015Date of Patent: August 16, 2016Assignee: ET WATER SYSTEMS, INC.Inventors: Patrick B. Halahan, J. Patrick McIntyre, Mark Coopersmith, Mark Puckett
-
Publication number: 20150313098Abstract: A smart irrigation system for an irrigation controller associated with an irrigation site is described herein. The smart irrigation system comprises a central control system having a user interface and a smart scheduler. The central control system is configured to receive a landscape information associated with the irrigation site. The landscape information is provided by a user via the user interface. The central control system is further configured to receive an environmental information associated with the irrigation site. The central control system is further configured to derive an irrigation schedule for the irrigation site based on the landscape information and the environmental information. The central control system being further configured to send the irrigation schedule. The smart scheduler comprises a data receiver, a processor, and a signal interface. The data receiver is configured to receive the irrigation schedule.Type: ApplicationFiled: February 2, 2015Publication date: November 5, 2015Inventors: Patrick B. Halahan, J. Patrick McIntyre, Mark Coopersmith, Mark Puckett
-
Patent number: 8948921Abstract: A smart irrigation system for an irrigation controller associated with an irrigation site is described herein. The smart irrigation system comprises a central control system having a user interface and a smart scheduler. The central control system is configured to derive and send an irrigation schedule for the irrigation. The smart scheduler comprises a data receiver, a processor, and a signal interface. The data receiver is configured to receive the irrigation schedule. The processor is configured to convert the irrigation schedule to a series of control signals that the irrigation controller recognizes. The signal interface is configured to connect to the irrigation controller and to send the series of control signals to the irrigation controller. The system uses weather data and irrigation site-specific information to automatically apply the optimal irrigation schedule. User are able to remotely control the irrigation via networks such as Internet.Type: GrantFiled: November 21, 2011Date of Patent: February 3, 2015Assignee: ET Water Systems, Inc.Inventors: Patrick B. Halahan, J. Patrick McIntyre, Mark Coopersmith, Mark Puckett
-
Publication number: 20120303168Abstract: A smart irrigation system for an irrigation controller associated with an irrigation site is described herein. The smart irrigation system comprises a central control system having a user interface and a smart scheduler. The central control system is configured to derive and send an irrigation schedule for the irrigation site. The smart scheduler comprises a data receiver, a processor, and a signal interface. The data receiver is configured to receive the irrigation schedule. The processor is configured to convert the irrigation schedule to a series of control signals that the irrigation controller recognizes. The signal interface is configured to connect to the irrigation controller and to send the series of control signals to the irrigation controller. The system uses weather data and irrigation site-specific information to automatically apply the optimal irrigation schedule. Users are able to remotely control the irrigation via networks such as Internet.Type: ApplicationFiled: November 21, 2011Publication date: November 29, 2012Applicant: ET Water Systems, Inc.Inventors: Patrick B. Halahan, J. Patrick McIntyre, Mark Coopersmith, Mark Puckett
-
Publication number: 20120009183Abstract: A method for treating acute or chronic pancreatitis in a subject comprises administering to the subject a therapeutically effective amount of an ACE2 inhibitor.Type: ApplicationFiled: June 28, 2011Publication date: January 12, 2012Applicant: Ore Pharmaceuticals Inc.Inventors: Louis Anthony Tartaglia, Thomas Michael Barnes, Robert Mark Coopersmith, Scott Edward Malstrom, David William White, Luz-Maria Guzman
-
Patent number: 7842709Abstract: A method for treating an inflammatory disease of the digestive tract, for example inflammatory bowel disease, in a subject comprises administering to the subject a therapeutically effective amount of a compound selected from the group consisting of (S,S)-2- [1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl]-ethylamino]-4-methylpentanoic acid and pharmaceutically acceptable salts thereof.Type: GrantFiled: September 7, 2007Date of Patent: November 30, 2010Assignee: Ore Pharmaceuticals Inc.Inventors: Louis Anthony Tartaglia, Thomas Michael Barnes, Robert Mark Coopersmith, Scott Edward Malstrom, David William White, Dominic Picarella
-
Publication number: 20100035848Abstract: A method for managing or treating an inflammatory, erosive, dyspeptic or reflux disorder of the proximal digestive tract of a subject comprises administering to the subject a therapeutically effective amount of an ACE2 inhibitor. A therapeutic combination, useful to treat any disease or condition in which an NSAID is indicated, comprises an NSAID in an anti-inflammatory, analgesic or antipyretic effective amount and a gastroprotective agent that comprises an ACE2 inhibitor in an amount effective to protect mucosal surfaces of the proximal digestive tract from erosion or ulceration induced by the NSAID.Type: ApplicationFiled: March 10, 2009Publication date: February 11, 2010Inventors: Stephen Richard Donahue, Michael David Jacobson, John Joseph Byrnes, III, Luz-Maria Guzman, Thomas Michael Barnes, Robert Mark Coopersmith, Scott Edward Malstrom
-
Publication number: 20100029734Abstract: A method for selecting a breast cancer patient for therapy with an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor, comprises (a) determining whether the cancer comprises a tumor that is estrogen receptor positive (ER+) and (b) selecting the patient for such therapy only if the cancer is determined to comprise an ER+ tumor. A method for treating breast cancer in a patient further comprises (c) administering to the patient, if so selected, an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor. A method for treating a breast tumor in a patient having SERM-resistant ER+ breast cancer comprises administering to the patient an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor.Type: ApplicationFiled: May 6, 2009Publication date: February 4, 2010Applicant: Ore Pharmaceuticals Inc.Inventors: David White, Shengfang Jin, Robert Mark Coopersmith, Denzyl Fernandes, Xuena Lin
-
Publication number: 20090192220Abstract: A method for treating a solid tumor in a subject comprises administering to the subject an ACAT inhibitory compound or a prodrug thereof, for example avasimibe, wherein (a) the solid tumor is at least about 2 mm in diameter and (b) the compound or prodrug thereof is administered in an amount that is therapeutically effective, but ineffective to cause unacceptable toxicity to normoxic tissues.Type: ApplicationFiled: November 17, 2008Publication date: July 30, 2009Applicant: Ore Pharmaceuticals Inc.Inventors: David William White, Jin Shengfang, Robert Mark Coopersmith, Scott Edward Malstrom, Thi T. Nguyen
-
Publication number: 20090186014Abstract: A method for treating acute or chronic pancreatitis in a subject comprises administering to the subject a therapeutically effective amount of an ACE2 inhibitor.Type: ApplicationFiled: October 9, 2008Publication date: July 23, 2009Applicant: Ore Pharmaceuticals Inc.Inventors: Louis Anthony Tartaglia, Thomas Michael Barnes, Robert Mark Coopersmith, Scott Edward Malstrom, David William White, Luz-Maria Guzman
-
Publication number: 20090012052Abstract: A method for selecting a female breast cancer patient for AT1 receptor antagonist therapy comprises (a) determining whether the cancer comprises a tumor that is ER+ and/or PR+; and (b) selecting the patient for AT1 receptor antagonist therapy only if the cancer is determined to comprise an ER+ and/or PR+ tumor. A method for treating breast cancer in a female patient further comprises (c) administering to the patient, if so selected, an AT1 receptor antagonist according to a regimen effective to reduce growth, invasiveness and/or metastasis of the tumor.Type: ApplicationFiled: April 9, 2008Publication date: January 8, 2009Applicant: Ore Pharmaceuticals Inc.Inventors: Robert Mark Coopersmith, David William White, Shengfang Jin, Denzyl Fernandes, Xuena Lin
-
Publication number: 20080234345Abstract: A method is provided for reducing or alleviating inflammation or a pathological process associated therewith or secondary thereto in a subject having an inflammatory disease of the digestive tract. The method comprises administering to the subject an anti-inflammatorily effective amount of an ACE2 inhibitor.Type: ApplicationFiled: September 7, 2007Publication date: September 25, 2008Applicant: Gene Logic Inc.Inventors: Louis Anthony Tartaglia, Thomas Michael Barnes, Robert Mark Coopersmith, Scott Edward Malstrom, David William White, Dominic Picarella
-
Publication number: 20080132474Abstract: A method for selecting a female breast cancer patient for AT1 receptor antagonist therapy comprises (a) determining whether the cancer comprises a tumor that is ER+ and/or PR+; and (b) selecting the patient for AT1 receptor antagonist therapy only if the cancer is determined to comprise an ER+ and/or PR+ tumor. A method for treating breast cancer in a female patient further comprises (c) administering to the patient, if so selected, an AT1 receptor antagonist according to a regimen effective to reduce growth, invasiveness and/or metastasis of the tumor.Type: ApplicationFiled: November 6, 2007Publication date: June 5, 2008Applicant: Gene Logic Inc.Inventors: Robert Mark Coopersmith, David William White, Shengfang Jin, Denzyl Fernandes, Xuena Lin